Fulcrum Therapeutics Inc. (FULC) expected to report EPS of $Fulcrum Therapeutics, Inc. for the current quarter

In the latest session, Fulcrum Therapeutics Inc. (NASDAQ: FULC) closed at $3.42 up 11.40% from its previous closing price of $3.07. In other words, the price has increased by $+0.3500 from its previous closing price. On the day, 1049734 shares were traded. FULC stock price reached its highest trading level at $3.5400 during the session, while it also had its lowest trading level at $3.0250.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



For a deeper understanding of Fulcrum Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.00 and its Current Ratio is at 21.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 10 when Tourangeau Greg sold 210 shares for $3.31 per share. The transaction valued at 695 led to the insider holds 15,992 shares of the business.

RA CAPITAL MANAGEMENT, L.P. bought 1,923,076 shares of FULC for $24,999,988 on Jan 20. The 10% Owner now owns 11,609,704 shares after completing the transaction at $13.00 per share. On Jan 13, another insider, Gould Robert J, who serves as the Interim President & CEO of the company, sold 6,766 shares for $15.00 each. As a result, the insider received 101,490 and left with 499,864 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FULC now has a Market Capitalization of 200.72M and an Enterprise Value of 11.22M. For the stock, the TTM Price-to-Sale (P/S) ratio is 53.30 while its Price-to-Book (P/B) ratio in mrq is 0.69. Its current Enterprise Value per Revenue stands at 2.77 whereas that against EBITDA is -0.10.

Stock Price History:

Over the past 52 weeks, FULC has reached a high of $15.00, while it has fallen to a 52-week low of $2.25. The 50-Day Moving Average of the stock is 2.9748, while the 200-Day Moving Average is calculated to be 6.9028.

Shares Statistics:

For the past three months, FULC has traded an average of 1.24M shares per day and 656.62k over the past ten days. A total of 59.72M shares are outstanding, with a floating share count of 48.86M. Insiders hold about 4.82% of the company’s shares, while institutions hold 90.44% stake in the company. Shares short for FULC as of Apr 27, 2023 were 4.78M with a Short Ratio of 4.78M, compared to 4.94M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.73% and a Short% of Float of 9.55%.

Earnings Estimates

There are Fulton Financial Corporation different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $3.42, with high estimates of $65.21 and low estimates of $61.94.

EPS for the following year is $Stocks, with Stocks analysts recommending between $Stocks and $ETF.